USA Neurological Biomarkers Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Neurological Biomarkers market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Neurological Biomarkers market. Detailed analysis of key players, along with key growth strategies adopted by Neurological Biomarkers industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Alseres Pharmaceuticals, Inc

    • Bio-Rad Laboratories, Inc

    • AbaStar MDx, Inc

    • Acumen Pharmaceuticals

    • Thermo Fisher Scientific Inc

    • Myriad RBM

    • QIAGEN

    • BANYAN BIOMARKERS, INC

    • Abbott

    • Athena Diagnostics

    By Type:

    • Metabolomic

    • Genomic

    • Proteomic

    • Imaging

    • Others

    By End-User:

    • Research Organizations

    • Hospital Laboratories

    • Independent Clinical Diagnostic Centers

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Biomarkers Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Neurological Biomarkers Market Size and Growth Rate of Metabolomic from 2016 to 2027

      • 1.3.2 USA Neurological Biomarkers Market Size and Growth Rate of Genomic from 2016 to 2027

      • 1.3.3 USA Neurological Biomarkers Market Size and Growth Rate of Proteomic from 2016 to 2027

      • 1.3.4 USA Neurological Biomarkers Market Size and Growth Rate of Imaging from 2016 to 2027

      • 1.3.5 USA Neurological Biomarkers Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Neurological Biomarkers Market Size and Growth Rate of Research Organizations from 2016 to 2027

      • 1.4.2 USA Neurological Biomarkers Market Size and Growth Rate of Hospital Laboratories from 2016 to 2027

      • 1.4.3 USA Neurological Biomarkers Market Size and Growth Rate of Independent Clinical Diagnostic Centers from 2016 to 2027

      • 1.4.4 USA Neurological Biomarkers Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Neurological Biomarkers Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurological Biomarkers by Major Types

      • 3.4.1 Market Size and Growth Rate of Metabolomic

      • 3.4.2 Market Size and Growth Rate of Genomic

      • 3.4.3 Market Size and Growth Rate of Proteomic

      • 3.4.4 Market Size and Growth Rate of Imaging

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Neurological Biomarkers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurological Biomarkers by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurological Biomarkers in Research Organizations

      • 4.4.2 Market Size and Growth Rate of Neurological Biomarkers in Hospital Laboratories

      • 4.4.3 Market Size and Growth Rate of Neurological Biomarkers in Independent Clinical Diagnostic Centers

      • 4.4.4 Market Size and Growth Rate of Neurological Biomarkers in Others

    5 Market Analysis by Regions

    • 5.1 USA Neurological Biomarkers Production Analysis by Regions

    • 5.2 USA Neurological Biomarkers Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Neurological Biomarkers Landscape Analysis

    • 6.1 West USA Neurological Biomarkers Landscape Analysis by Major Types

    • 6.2 West USA Neurological Biomarkers Landscape Analysis by Major End-Users

    7 South USA Neurological Biomarkers Landscape Analysis

    • 7.1 South USA Neurological Biomarkers Landscape Analysis by Major Types

    • 7.2 South USA Neurological Biomarkers Landscape Analysis by Major End-Users

    8 Middle West USA Neurological Biomarkers Landscape Analysis

    • 8.1 Middle West USA Neurological Biomarkers Landscape Analysis by Major Types

    • 8.2 Middle West USA Neurological Biomarkers Landscape Analysis by Major End-Users

    9 Northeast USA Neurological Biomarkers Landscape Analysis

    • 9.1 Northeast USA Neurological Biomarkers Landscape Analysis by Major Types

    • 9.2 Northeast USA Neurological Biomarkers Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Alseres Pharmaceuticals, Inc

        • 10.1.1 Alseres Pharmaceuticals, Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bio-Rad Laboratories, Inc

        • 10.2.1 Bio-Rad Laboratories, Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 AbaStar MDx, Inc

        • 10.3.1 AbaStar MDx, Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Acumen Pharmaceuticals

        • 10.4.1 Acumen Pharmaceuticals Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Thermo Fisher Scientific Inc

        • 10.5.1 Thermo Fisher Scientific Inc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Myriad RBM

        • 10.6.1 Myriad RBM Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 QIAGEN

        • 10.7.1 QIAGEN Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 BANYAN BIOMARKERS, INC

        • 10.8.1 BANYAN BIOMARKERS, INC Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Abbott

        • 10.9.1 Abbott Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Athena Diagnostics

        • 10.10.1 Athena Diagnostics Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Metabolomic from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Genomic from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Proteomic from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Imaging from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Research Organizations from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Hospital Laboratories from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Independent Clinical Diagnostic Centers from 2016 to 2027

    • Figure USA Neurological Biomarkers Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Neurological Biomarkers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Neurological Biomarkers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Neurological Biomarkers

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurological Biomarkers by Different Types from 2016 to 2027

    • Table Consumption Share of Neurological Biomarkers by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Metabolomic

    • Figure Market Size and Growth Rate of Genomic

    • Figure Market Size and Growth Rate of Proteomic

    • Figure Market Size and Growth Rate of Imaging

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Neurological Biomarkers by Different End-Users from 2016 to 2027

    • Table Consumption Share of Neurological Biomarkers by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Research Organizations

    • Figure Market Size and Growth Rate of Hospital Laboratories

    • Figure Market Size and Growth Rate of Independent Clinical Diagnostic Centers

    • Figure Market Size and Growth Rate of Others

    • Table USA Neurological Biomarkers Production by Regions

    • Table USA Neurological Biomarkers Production Share by Regions

    • Figure USA Neurological Biomarkers Production Share by Regions in 2016

    • Figure USA Neurological Biomarkers Production Share by Regions in 2021

    • Figure USA Neurological Biomarkers Production Share by Regions in 2027

    • Table USA Neurological Biomarkers Consumption by Regions

    • Table USA Neurological Biomarkers Consumption Share by Regions

    • Figure USA Neurological Biomarkers Consumption Share by Regions in 2016

    • Figure USA Neurological Biomarkers Consumption Share by Regions in 2021

    • Figure USA Neurological Biomarkers Consumption Share by Regions in 2027

    • Table West USA Neurological Biomarkers Consumption by Types from 2016 to 2027

    • Table West USA Neurological Biomarkers Consumption Share by Types from 2016 to 2027

    • Figure West USA Neurological Biomarkers Consumption Share by Types in 2016

    • Figure West USA Neurological Biomarkers Consumption Share by Types in 2021

    • Figure West USA Neurological Biomarkers Consumption Share by Types in 2027

    • Table West USA Neurological Biomarkers Consumption by End-Users from 2016 to 2027

    • Table West USA Neurological Biomarkers Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Neurological Biomarkers Consumption Share by End-Users in 2016

    • Figure West USA Neurological Biomarkers Consumption Share by End-Users in 2021

    • Figure West USA Neurological Biomarkers Consumption Share by End-Users in 2027

    • Table South USA Neurological Biomarkers Consumption by Types from 2016 to 2027

    • Table South USA Neurological Biomarkers Consumption Share by Types from 2016 to 2027

    • Figure South USA Neurological Biomarkers Consumption Share by Types in 2016

    • Figure South USA Neurological Biomarkers Consumption Share by Types in 2021

    • Figure South USA Neurological Biomarkers Consumption Share by Types in 2027

    • Table South USA Neurological Biomarkers Consumption by End-Users from 2016 to 2027

    • Table South USA Neurological Biomarkers Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Neurological Biomarkers Consumption Share by End-Users in 2016

    • Figure South USA Neurological Biomarkers Consumption Share by End-Users in 2021

    • Figure South USA Neurological Biomarkers Consumption Share by End-Users in 2027

    • Table Middle West USA Neurological Biomarkers Consumption by Types from 2016 to 2027

    • Table Middle West USA Neurological Biomarkers Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Neurological Biomarkers Consumption Share by Types in 2016

    • Figure Middle West USA Neurological Biomarkers Consumption Share by Types in 2021

    • Figure Middle West USA Neurological Biomarkers Consumption Share by Types in 2027

    • Table Middle West USA Neurological Biomarkers Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Neurological Biomarkers Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Neurological Biomarkers Consumption Share by End-Users in 2016

    • Figure Middle West USA Neurological Biomarkers Consumption Share by End-Users in 2021

    • Figure Middle West USA Neurological Biomarkers Consumption Share by End-Users in 2027

    • Table Northeast USA Neurological Biomarkers Consumption by Types from 2016 to 2027

    • Table Northeast USA Neurological Biomarkers Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Neurological Biomarkers Consumption Share by Types in 2016

    • Figure Northeast USA Neurological Biomarkers Consumption Share by Types in 2021

    • Figure Northeast USA Neurological Biomarkers Consumption Share by Types in 2027

    • Table Northeast USA Neurological Biomarkers Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Neurological Biomarkers Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Neurological Biomarkers Consumption Share by End-Users in 2016

    • Figure Northeast USA Neurological Biomarkers Consumption Share by End-Users in 2021

    • Figure Northeast USA Neurological Biomarkers Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Alseres Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alseres Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Alseres Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Alseres Pharmaceuticals, Inc

    • Table Product and Service Introduction of Alseres Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Bio-Rad Laboratories, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories, Inc

    • Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories, Inc

    • Figure Revenue and Market Share Analysis of Bio-Rad Laboratories, Inc

    • Table Product and Service Introduction of Bio-Rad Laboratories, Inc

    • Table Company Profile and Development Status of AbaStar MDx, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbaStar MDx, Inc

    • Figure Sales and Growth Rate Analysis of AbaStar MDx, Inc

    • Figure Revenue and Market Share Analysis of AbaStar MDx, Inc

    • Table Product and Service Introduction of AbaStar MDx, Inc

    • Table Company Profile and Development Status of Acumen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acumen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Acumen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Acumen Pharmaceuticals

    • Table Product and Service Introduction of Acumen Pharmaceuticals

    • Table Company Profile and Development Status of Thermo Fisher Scientific Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific Inc

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific Inc

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific Inc

    • Table Product and Service Introduction of Thermo Fisher Scientific Inc

    • Table Company Profile and Development Status of Myriad RBM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad RBM

    • Figure Sales and Growth Rate Analysis of Myriad RBM

    • Figure Revenue and Market Share Analysis of Myriad RBM

    • Table Product and Service Introduction of Myriad RBM

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of BANYAN BIOMARKERS, INC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BANYAN BIOMARKERS, INC

    • Figure Sales and Growth Rate Analysis of BANYAN BIOMARKERS, INC

    • Figure Revenue and Market Share Analysis of BANYAN BIOMARKERS, INC

    • Table Product and Service Introduction of BANYAN BIOMARKERS, INC

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Athena Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Athena Diagnostics

    • Figure Sales and Growth Rate Analysis of Athena Diagnostics

    • Figure Revenue and Market Share Analysis of Athena Diagnostics

    • Table Product and Service Introduction of Athena Diagnostics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.